140 related articles for article (PubMed ID: 20410441)
1. Differential association modes of the thrombin receptor PAR1 with Galphai1, Galpha12, and beta-arrestin 1.
Ayoub MA; Trinquet E; Pfleger KD; Pin JP
FASEB J; 2010 Sep; 24(9):3522-35. PubMed ID: 20410441
[TBL] [Abstract][Full Text] [Related]
2. Real-time analysis of agonist-induced activation of protease-activated receptor 1/Galphai1 protein complex measured by bioluminescence resonance energy transfer in living cells.
Ayoub MA; Maurel D; Binet V; Fink M; Prézeau L; Ansanay H; Pin JP
Mol Pharmacol; 2007 May; 71(5):1329-40. PubMed ID: 17267663
[TBL] [Abstract][Full Text] [Related]
3. N-linked glycosylation of protease-activated receptor-1 at extracellular loop 2 regulates G-protein signaling bias.
Soto AG; Smith TH; Chen B; Bhattacharya S; Cordova IC; Kenakin T; Vaidehi N; Trejo J
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):E3600-8. PubMed ID: 26100877
[TBL] [Abstract][Full Text] [Related]
4. Activated protein C promotes protease-activated receptor-1 cytoprotective signaling through β-arrestin and dishevelled-2 scaffolds.
Soh UJ; Trejo J
Proc Natl Acad Sci U S A; 2011 Dec; 108(50):E1372-80. PubMed ID: 22106258
[TBL] [Abstract][Full Text] [Related]
5. Termination of protease-activated receptor-1 signaling by beta-arrestins is independent of receptor phosphorylation.
Chen CH; Paing MM; Trejo J
J Biol Chem; 2004 Mar; 279(11):10020-31. PubMed ID: 14699102
[TBL] [Abstract][Full Text] [Related]
6. Protease-activated receptor-1 (PAR1) acts via a novel Galpha13-dishevelled axis to stabilize beta-catenin levels.
Turm H; Maoz M; Katz V; Yin YJ; Offermanns S; Bar-Shavit R
J Biol Chem; 2010 May; 285(20):15137-15148. PubMed ID: 20223821
[TBL] [Abstract][Full Text] [Related]
7. Transactivation of the PAR1-PAR2 heterodimer by thrombin elicits β-arrestin-mediated endosomal signaling.
Lin H; Trejo J
J Biol Chem; 2013 Apr; 288(16):11203-15. PubMed ID: 23476015
[TBL] [Abstract][Full Text] [Related]
8. Galpha12/13- and rho-dependent activation of phospholipase C-epsilon by lysophosphatidic acid and thrombin receptors.
Hains MD; Wing MR; Maddileti S; Siderovski DP; Harden TK
Mol Pharmacol; 2006 Jun; 69(6):2068-75. PubMed ID: 16554409
[TBL] [Abstract][Full Text] [Related]
9. Biased signaling at chemokine receptors.
Corbisier J; Galès C; Huszagh A; Parmentier M; Springael JY
J Biol Chem; 2015 Apr; 290(15):9542-54. PubMed ID: 25614627
[TBL] [Abstract][Full Text] [Related]
10. Protease-activated receptor-2 simultaneously directs beta-arrestin-1-dependent inhibition and Galphaq-dependent activation of phosphatidylinositol 3-kinase.
Wang P; DeFea KA
Biochemistry; 2006 Aug; 45(31):9374-85. PubMed ID: 16878972
[TBL] [Abstract][Full Text] [Related]
11. Protease-activated receptor 1 (PAR1) coupling to G(q/11) but not to G(i/o) or G(12/13) is mediated by discrete amino acids within the receptor second intracellular loop.
McCoy KL; Gyoneva S; Vellano CP; Smrcka AV; Traynelis SF; Hepler JR
Cell Signal; 2012 Jun; 24(6):1351-60. PubMed ID: 22306780
[TBL] [Abstract][Full Text] [Related]
12. Different effects of the different natural CC chemokine receptor 2b ligands on beta-arrestin recruitment, Gαi signaling, and receptor internalization.
Berchiche YA; Gravel S; Pelletier ME; St-Onge G; Heveker N
Mol Pharmacol; 2011 Mar; 79(3):488-98. PubMed ID: 21088225
[TBL] [Abstract][Full Text] [Related]
13. Identification of novel species-selective agonists of the G-protein-coupled receptor GPR35 that promote recruitment of β-arrestin-2 and activate Gα13.
Jenkins L; Brea J; Smith NJ; Hudson BD; Reilly G; Bryant NJ; Castro M; Loza MI; Milligan G
Biochem J; 2010 Dec; 432(3):451-9. PubMed ID: 20919992
[TBL] [Abstract][Full Text] [Related]
14. Agonist-induced formation of unproductive receptor-G
Okashah N; Wright SC; Kawakami K; Mathiasen S; Zhou J; Lu S; Javitch JA; Inoue A; Bouvier M; Lambert NA
Proc Natl Acad Sci U S A; 2020 Sep; 117(35):21723-21730. PubMed ID: 32817560
[TBL] [Abstract][Full Text] [Related]
15. Receptor selectivity between the G proteins Gα
Mackenzie AE; Quon T; Lin LC; Hauser AS; Jenkins L; Inoue A; Tobin AB; Gloriam DE; Hudson BD; Milligan G
FASEB J; 2019 Apr; 33(4):5005-5017. PubMed ID: 30601679
[TBL] [Abstract][Full Text] [Related]
16. Functional selectivity of natural and synthetic prostaglandin EP4 receptor ligands.
Leduc M; Breton B; Galés C; Le Gouill C; Bouvier M; Chemtob S; Heveker N
J Pharmacol Exp Ther; 2009 Oct; 331(1):297-307. PubMed ID: 19584306
[TBL] [Abstract][Full Text] [Related]
17. Live cell optical assay for precise characterization of receptors coupling to Gα12.
Masuho I; Skamangas NK; Martemyanov KA
Basic Clin Pharmacol Toxicol; 2020 Jun; 126 Suppl 6(Suppl 6):88-95. PubMed ID: 30916867
[TBL] [Abstract][Full Text] [Related]
18. Interaction of Protease-Activated Receptor 2 with G Proteins and β-Arrestin 1 Studied by Bioluminescence Resonance Energy Transfer.
Ayoub MA; Pin JP
Front Endocrinol (Lausanne); 2013; 4():196. PubMed ID: 24391627
[TBL] [Abstract][Full Text] [Related]
19. Leukotriene D4 activates distinct G-proteins in intestinal epithelial cells to regulate stress fibre formation and to generate intracellular Ca2+ mobilisation and ERK1/2 activation.
Nielsen CK; Massoumi R; Sonnerlind M; Sjölander A
Exp Cell Res; 2005 Jan; 302(1):31-9. PubMed ID: 15541723
[TBL] [Abstract][Full Text] [Related]
20. Pepducin targeting the C-X-C chemokine receptor type 4 acts as a biased agonist favoring activation of the inhibitory G protein.
Quoyer J; Janz JM; Luo J; Ren Y; Armando S; Lukashova V; Benovic JL; Carlson KE; Hunt SW; Bouvier M
Proc Natl Acad Sci U S A; 2013 Dec; 110(52):E5088-97. PubMed ID: 24309376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
